Heart Healthy Lenoir Project, Kinston Enterprise Center
Kinston, North Carolina, 28501, United States
NCT Number: NCT01433484
This study aims to reduce cardiovascular disease (CVD) risk and disparities in risk by improving lifestyle factors which underlie the development of CVD. The first steps will involve conducting a comprehensive formative evaluation to assess individual, interpersonal, organizational, community, and policy factors relevant to CVD risk and risk reduction in Lenoir County. This will be followed by a community-based lifestyle intervention program designed to improve eating patterns, promote physical activity, and for those who are interested, support weight loss. A randomized trial comparing the effectiveness of two community based weight maintenance interventions will also be conducted. Community-wide policy and environmental change interventions will also be implemented to support the individual-level interventions, including partnerships with businesses to promote a healthy environment through innovative economic opportunities. In addition, this project will explore genetic factors associated with cardiovascular disease risk and treatment success.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Kinston, North Carolina, 28501, United States
The lifestyle intervention will enroll 350 participants. The initial lifestyle component of this study, which lasts for 4-6 months, will be provided to all participants. Participants may chose from one of two intervention formats, each with 4 contacts: individual counseling with at least one face-to-face visit and the rest face-to-face or by phone or 4 group sessions. The dietary intervention will focus on improving fat and carbohydrate quality. For fat intake, the goals include 2-4 servings per day of polyunsaturated fat primarily from plant sources and minimal intake of trans fat. For carbohydrate intake, the goals include increased intake of whole grains, fruits and vegetables, and beans and reduced consumption of refined carbohydrates. The physical activity intervention will primarily focus on walking with a goal of 7500 to 10,000 steps per day or, for those who do not wish to use a pedometer, 30 minutes of walking a day. Muscle strengthening activities will also be recommended. At the 4-6 month follow-up measures, those who wish to take part in a weight loss study may do so and those who do not will continue in a maintenance of lifestyle intervention.
The investigators anticipate approximately 200 participants will take part in the weight loss component of this study, which consists of a 6 month intensive weight loss intervention. Participants may choose from two intervention formats: 16 weekly group sessions or 5 group sessions and 10 phone counseling sessions. The weight loss goal will be 5% of body weight. At the conclusion of this program, those who lose at least 8 pounds and are willing to take part in a 1 year maintenance of weight loss intervention will be RANDOMIZED to one of two maintenance of weight loss programs. One maintenance arm will receive monthly telephone contacts for one year, while the other arm will receive bi-monthly phone contacts.
Follow-up measures for all participants will be at approximately 6, 12, 18, and 24 months.
Another related part of the project will use a systems approach to develop models integrating clinical and genomic data. Researchers have developed and tested an approach referred to as the SAMARA (Supporting A Multidisciplinary Approach to Research in Atherosclerosis) Project that applies recent, major advances in biomedical and computational sciences at UNC to develop a deeper understanding of human CVD. The Heart-Healthy Lenoir Project will expand studies into the community, using this methodology to: 1) determine the prevalence of genomic risk signatures in high-risk community populations using genome-wide Single Nucleotide Polymorphism (SNP) analysis; 2) develop novel genomic models incorporating high-risk features in this population; and 3) determine whether genomic signatures can be used to predict responsiveness to interventions that underlie CVD disparities. Participants who consent to this component of the project will have a blood specimen obtained at baseline.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Additional Exclusion Criteria - Weight Loss Intervention:
As the maintenance of weight loss randomized trial does not begin until a year after the start of this study, the intervention and control conditions are not yet specified. This will occur before randomization and this section will be updated before the first participant is randomized.
Time frame: 6 months
Fruit and vegetable intake will be measured by the Block fruit and vegetable sceener and by blood carotenoids
Time frame: 1 year after maintenance of weight loss trial begins
Weight will be measured by electronic scale
Time frame: 6m, 12m, 18m, 24 m
Measured by questionnaire and pedometer
Time frame: 6, 12, 18, 24 months
measured by automated device
Time frame: 12, 24 months
total and HDL cholesterol measured by commercial lab
Time frame: 6, 12, 24 months
measured by commercial lab
Time frame: 12, 18, and 24 months
Measured by Block fruit and vegetable screener
Time frame: 6, 12, 18, 24
Measured by electronic scale
Time frame: 6, 12, 24 months
SF-12 instrument
Time frame: 6-, 12-, 18- and 24-month follow-up
A systems approach to developing genomic models integrating clinical and genomic data.
University of North Carolina, Chapel Hill
Other
Community-Based Lifestyle Intervention to Reduce CVD Risk & Disparities in Risk
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02399423
Body Weight, Body Weight Changes
Glasgow, United Kingdom
View Trial DetailsNCT00847574
Behavior, Body Weight
University Park, Pennsylvania, United States
View Trial DetailsNCT02808910
Behavior, Body Weight
Feiring, Norway
View Trial DetailsNCT02454127
Body Weight, Body Weight Changes
View Trial Details